Form 8.3 - Aon Plc

By

Regulatory News | 04 Dec, 2020

Updated : 15:21

RNS Number : 6440H
BlackRock Group
04 December 2020
 

Ap19

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.       KEY INFORMATION

 

Name of person dealing (Note 1)

BlackRock, Inc.

Company dealt in

Aon plc

US$0.01 ordinary shares

Date of dealing

03 December 2020

 

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

14,501,761 (6.33%)

18,188 (0.00%)

(2) Derivatives (other than options)

110,615 (0.04%)

2,475,016 (1.08%)

(3) Options and agreements to purchase/sell

0 (0.00%)

0 (0.00%)

Total

14,612,376 (6.38%)

2,493,204 (1.08%)

       

 

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

       

 

Ap20

 

 

1.       DEALINGS (Note 4)

 

(a)      Purchases and sales

 

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

Purchase

307

USD 210.0598

Purchase

3,466

USD 210.1800

Purchase

740

USD 210.0750

Purchase

341

USD 210.1667

Sale

82,331

USD 208.3303

Sale

15,537

USD 210.0440

Sale

4,085

USD 210.1800

Sale

462

USD 209.9959

Sale

126

USD 210.0120

   

Please note: there was also a Transfer Out of 447 Shares

 

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

CFD

Increasing Long

280

USD 210.1739

CFD

Increasing Long

31

USD 210.1800

CFD

Increasing Long

86

USD 210.1991

CFD

Reducing Short

1,228

USD 209.9273

CFD

Reducing Short

1,167

USD 210.0062

CFD

Reducing Short

562

USD 210.0407

CFD

Reducing Short

443

USD 210.0409

CFD

Reducing Short

160

USD 210.0456

CFD

Increasing Short

101

USD 210.0264

   

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Stock on Loan

341,799

N/A

Return of Stock on Loan

250,099

N/A

   

 

Ap21

 

2.       OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any

other person relating to the voting rights of any relevant securities under any option referred to on this

form or relating to the voting rights or future acquisition or disposal of any relevant securities to which

any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

None

 

 

 

Is a Supplemental Form 8 attached? (Note 9)                                    NO

 

Date of disclosure

04 December 2020

Contact name

Jana Blumenstein

Telephone number

+44 20 7743 3650

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEFSLFDLESSEDE

Last news